The Food and Drug Administration has granted Pfizer-BioNTech authorization to administer a low booster dose of its COVID-19 vaccine to children ages five to 11.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.